Surgery-first versus neoadjuvant chemotherapy in stage I (cT1c) triple-negative breast cancer: A critical reappraisal

M. Dediu, C. Zielinski, V. Preoteasa, A. Bulzan

Open source

DOI
10.1016/j.breast.2026.104913
Published
2026-12
Container
The Breast
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.breast.2026.104913,
  title = {Surgery-first versus neoadjuvant chemotherapy in stage I (cT1c) triple-negative breast cancer: A critical reappraisal},
  author = {M. Dediu and C. Zielinski and V. Preoteasa and A. Bulzan},
  year = {2026},
  journal = {The Breast},
  doi = {10.1016/j.breast.2026.104913},
  url = {https://doi.org/10.1016/j.breast.2026.104913}
}

RIS

TY  - JOUR
TI  - Surgery-first versus neoadjuvant chemotherapy in stage I (cT1c) triple-negative breast cancer: A critical reappraisal
AU  - M. Dediu
AU  - C. Zielinski
AU  - V. Preoteasa
AU  - A. Bulzan
PY  - 2026
JO  - The Breast
DO  - 10.1016/j.breast.2026.104913
UR  - https://doi.org/10.1016/j.breast.2026.104913
ER  - 

APA

Dediu, M., Zielinski, C., Preoteasa, V., & Bulzan, A. (2026). Surgery-first versus neoadjuvant chemotherapy in stage I (cT1c) triple-negative breast cancer: A critical reappraisal. The Breast. https://doi.org/10.1016/j.breast.2026.104913

Source records